Cargando…
Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer
The focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer system (MTX-NLPHS) that can transport methotrexate (MTX) in MCF-...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925353/ https://www.ncbi.nlm.nih.gov/pubmed/36793351 http://dx.doi.org/10.7150/ntno.81173 |
_version_ | 1784888049442750464 |
---|---|
author | Kumar, Rahul Srivastava, Vinish Ranjan Mahapatra, Supratim Dkhar, Daphika S Kumari, Rohini Prerna, Kumari Dubey, Vikash Kumar Chandra, Pranjal |
author_facet | Kumar, Rahul Srivastava, Vinish Ranjan Mahapatra, Supratim Dkhar, Daphika S Kumari, Rohini Prerna, Kumari Dubey, Vikash Kumar Chandra, Pranjal |
author_sort | Kumar, Rahul |
collection | PubMed |
description | The focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer system (MTX-NLPHS) that can transport methotrexate (MTX) in MCF-7 cell lines in a controlled manner through endocytosis via phosphatidylcholine. In this experiment, MTX is embedded with polylactic-co-glycolic acid (PLGA) in phosphatidylcholine, which acts as a liposomal framework for regulated drug delivery. Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and dynamic light scattering (DLS) were utilized to characterize the developed nanohybrid system. The particle size and encapsulation efficiency of the MTX-NLPHS were found to be 198 ± 8.44 nm and 86.48 ± 0.31 %, respectively, which is suitable for biological applications. The polydispersity index (PDI) and zeta potential of the final system were found to be 0.134 ± 0.048 and -28 ± 3.50 mV, respectively. The lower value of PDI showed the homogenous nature of the particle size, whereas higher negative zeta potential prevented the system from agglomeration. An in vitro release kinetics was conducted to see the release pattern of the system, which took 250 h for 100% drug release This kind of system may carry the drug for a long time in the circulatory system and prevent the drug discharge. Other cell culture assays such as 3-(4, 5-dimethyl thiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) and reactive oxygen species (ROS) monitoring were used to see the effect of inducers on the cellular system. MTT assay showed cell toxicity of MTX-NLPHS reduced at the lower concentration of the MTX, however, toxicity increased at the higher concentration of the MTX as compared to free MTX. ROS monitoring c revealed more scavenging of ROS using MTX-NLPHS as compared to free MTX. Confocal microscopy suggested the MTX-NLPHS induced more nuclear elongation with cell shrinkage comparatively. |
format | Online Article Text |
id | pubmed-9925353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-99253532023-02-14 Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer Kumar, Rahul Srivastava, Vinish Ranjan Mahapatra, Supratim Dkhar, Daphika S Kumari, Rohini Prerna, Kumari Dubey, Vikash Kumar Chandra, Pranjal Nanotheranostics Research Paper The focus of this research is to design a bioengineered drug delivery vehicle that is efficient in anti-cancer drug delivery in a controlled manner. The experimental work focuses on constructing a methotrexate-loaded nano lipid polymer system (MTX-NLPHS) that can transport methotrexate (MTX) in MCF-7 cell lines in a controlled manner through endocytosis via phosphatidylcholine. In this experiment, MTX is embedded with polylactic-co-glycolic acid (PLGA) in phosphatidylcholine, which acts as a liposomal framework for regulated drug delivery. Scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and dynamic light scattering (DLS) were utilized to characterize the developed nanohybrid system. The particle size and encapsulation efficiency of the MTX-NLPHS were found to be 198 ± 8.44 nm and 86.48 ± 0.31 %, respectively, which is suitable for biological applications. The polydispersity index (PDI) and zeta potential of the final system were found to be 0.134 ± 0.048 and -28 ± 3.50 mV, respectively. The lower value of PDI showed the homogenous nature of the particle size, whereas higher negative zeta potential prevented the system from agglomeration. An in vitro release kinetics was conducted to see the release pattern of the system, which took 250 h for 100% drug release This kind of system may carry the drug for a long time in the circulatory system and prevent the drug discharge. Other cell culture assays such as 3-(4, 5-dimethyl thiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) and reactive oxygen species (ROS) monitoring were used to see the effect of inducers on the cellular system. MTT assay showed cell toxicity of MTX-NLPHS reduced at the lower concentration of the MTX, however, toxicity increased at the higher concentration of the MTX as compared to free MTX. ROS monitoring c revealed more scavenging of ROS using MTX-NLPHS as compared to free MTX. Confocal microscopy suggested the MTX-NLPHS induced more nuclear elongation with cell shrinkage comparatively. Ivyspring International Publisher 2023-01-16 /pmc/articles/PMC9925353/ /pubmed/36793351 http://dx.doi.org/10.7150/ntno.81173 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Kumar, Rahul Srivastava, Vinish Ranjan Mahapatra, Supratim Dkhar, Daphika S Kumari, Rohini Prerna, Kumari Dubey, Vikash Kumar Chandra, Pranjal Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer |
title | Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer |
title_full | Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer |
title_fullStr | Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer |
title_full_unstemmed | Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer |
title_short | Drug Encapsulated Lipid-Polymeric Nanohybrid as a Chemo-therapeutic Platform of Cancer |
title_sort | drug encapsulated lipid-polymeric nanohybrid as a chemo-therapeutic platform of cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925353/ https://www.ncbi.nlm.nih.gov/pubmed/36793351 http://dx.doi.org/10.7150/ntno.81173 |
work_keys_str_mv | AT kumarrahul drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer AT srivastavavinishranjan drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer AT mahapatrasupratim drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer AT dkhardaphikas drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer AT kumarirohini drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer AT prernakumari drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer AT dubeyvikashkumar drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer AT chandrapranjal drugencapsulatedlipidpolymericnanohybridasachemotherapeuticplatformofcancer |